Swedish Orphan Biovitrum AB (publ)

SOBI:Stockholmsborsen
RT Quote | Exchange | SEK
Last | 3:28 PM CET
159.50quote price arrow down-6.70 (-4.03%)
Volume
1,089,055
52 week range
154.90 - 169.10

...

Loading . . .

KEY STATS

  • Open166.65
  • Day High166.65
  • Day Low158.55
  • Prev Close166.20
  • 52 Week High169.10
  • 52 Week High Date01/04/21
  • 52 Week Low154.90
  • 52 Week Low Date01/14/21
  • Market Cap5,914.26M
  • Shares Out294.9M
  • 10 Day Average Volume768,766.64
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • 1 Year % Change-10.34

RATIOS/PROFITABILITY

  • EPS (TTM)10.54
  • P/E (TTM)15.13
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Swedish Orphan Biovitrum AB (publ) News

There is no recent news for this security.

Latest SOBI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within...
Hakan Bjorklund Ph.D.
Chairman
Guido Oelkers
President
Henrik Stenqvist
Chief Financial Officer
Anne De Jonge Schuermans Ph.D.
Chief Technology Officer
Torbjorn Hallberg
General Counsel
Address
Tomtebodavagen 23A
Solna
112 76
Sweden